Kombinirovannaya Terapiya Khronicheskogo Gepatita S Pri Vich-Infektsii
| AUTHOR | Ivanova Lyubov' |
| PUBLISHER | LAP Lambert Academic Publishing (10/25/2011) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
Mnogochislennye issledovaniya svidetel'stvuyut o vzaimnom vliyanii VICh i virusa gepatita S na techenie, kak VICh-infektsii, tak i khronicheskogo gepatita S. Odnoy iz osobennostey infektsii, vyzvannoy HSV, yavlyaetsya vysokiy risk razvitiya khronicheskoy formy bolezni, a pri sochetannoy infektsii HIV/HSV otmechaetsya bolee bystroe progressirovanie khronicheskoy bolezni pecheni i bol'shaya chastota razvitiya tsirroza, chem pri monoinfektsii HCV. S vvedeniem v klinicheskuyu praktiku antiretrovirusnoy terapii VICh-infektsii, uluchshilis' kachestvo i prodolzhitel'nost' zhizni patsientov. Vmeste s tem, posle vnedreniya VAART smertnost' ot bolezney pecheni uvelichilas' s 5-12% do 35-50%. Osnovnye printsipy lecheniya KhGS u VICh-infitsirovannykh sootvetstvuyut takovym u patsientov, ne zarazhennykh VICh. V nastoyashchee vremya, standartom terapii KhGS u VICh-infitsirovannykh patsientov yavlyaetsya naznachenie pegilirovannogo interferona-al'fa i ribavirina v techenie 48 nedel' vne zavisimosti ot genotipa virusa S. Dannykh ob effektivnosti i bezopasnosti kombinirovannoy terapii KhGS u VICh-infitsirovannykh patsientov bez priznakov tsirroza pecheni i ne poluchayushchikh VAART nedostatochno. Issledovaniyu etoy problemy i posvyashchena dannaya rabota.
Show More
Product Format
Product Details
ISBN-13:
9783846533628
ISBN-10:
3846533629
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
Russian
More Product Details
Page Count:
144
Carton Quantity:
56
Product Dimensions:
6.00 x 0.34 x 9.00 inches
Weight:
0.49 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Medical | General
Descriptions, Reviews, Etc.
publisher marketing
Mnogochislennye issledovaniya svidetel'stvuyut o vzaimnom vliyanii VICh i virusa gepatita S na techenie, kak VICh-infektsii, tak i khronicheskogo gepatita S. Odnoy iz osobennostey infektsii, vyzvannoy HSV, yavlyaetsya vysokiy risk razvitiya khronicheskoy formy bolezni, a pri sochetannoy infektsii HIV/HSV otmechaetsya bolee bystroe progressirovanie khronicheskoy bolezni pecheni i bol'shaya chastota razvitiya tsirroza, chem pri monoinfektsii HCV. S vvedeniem v klinicheskuyu praktiku antiretrovirusnoy terapii VICh-infektsii, uluchshilis' kachestvo i prodolzhitel'nost' zhizni patsientov. Vmeste s tem, posle vnedreniya VAART smertnost' ot bolezney pecheni uvelichilas' s 5-12% do 35-50%. Osnovnye printsipy lecheniya KhGS u VICh-infitsirovannykh sootvetstvuyut takovym u patsientov, ne zarazhennykh VICh. V nastoyashchee vremya, standartom terapii KhGS u VICh-infitsirovannykh patsientov yavlyaetsya naznachenie pegilirovannogo interferona-al'fa i ribavirina v techenie 48 nedel' vne zavisimosti ot genotipa virusa S. Dannykh ob effektivnosti i bezopasnosti kombinirovannoy terapii KhGS u VICh-infitsirovannykh patsientov bez priznakov tsirroza pecheni i ne poluchayushchikh VAART nedostatochno. Issledovaniyu etoy problemy i posvyashchena dannaya rabota.
Show More
Your Price
$75.67